Quantum Biopharma Ltd. Class B Subordinate Voting Shares (NASDAQ: QNTM)
37 Days left to seek lead plaintiff status.
The Complaint alleges that during the Class Period, Defendants repeatedly entered thousands of spoofed sell orders designed to create the false impression in the market that Quantum’s stock price was falling. These manipulative orders were calculated to (and successfully did) deceive or induce other investors to sell their holdings at artificially low prices. After driving the market price down, Defendants purchased shares at these artificially depressed levels and positioned themselves to profit. Meanwhile, investors, including Plaintiff, were baited into selling their shares at artificially depressed prices.